SCHEMBL562292

SCHEMBL562292

O=C1CC(=O)CC(c2cccc3ccccc23)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.58
TP53 P04637 2/20 0.58
RECQL P46063 1/20 0.58
MAPT P10636 4/20 0.50
GAA P10253 1/20 0.50
IDO1 P14902 1/20 0.50
KDM1A O60341 1/20 0.46
SLC6A4 P31645 3/20 0.43
DRD2 P14416 1/20 0.43
NPSR1 Q6W5P4 3/20 0.41
MAPK1 P28482 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
BLM P54132 2/20 0.41
KDM4E B2RXH2 1/20 0.41
TDP2 O95551 1/20 0.41
ALOX12 P18054 1/20 0.41
CASP3 P42574 1/20 0.41
HTT P42858 1/20 0.41
GALK1 P51570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25376201 0.85 MTNR1A (0.46) MTNR1ATP53RECQLMAPTGAA
SCHEMBL25373829 0.83 MTNR1A (0.44) MTNR1ATP53RECQLMAPTGAA
SCHEMBL27956975 0.82 MTNR1A (0.55) MTNR1ATP53RECQLMAPTIDO1
SCHEMBL657069 0.80 MTNR1A (0.57) MTNR1ATP53MAPTIDO1KDM1A
SCHEMBL17996703 0.80 MTNR1A (0.53) MTNR1ATP53MAPTGAAIDO1
SCHEMBL18625858 0.78 MTNR1A (0.51) MTNR1AMAPTIDO1KDM1ASLC6A4
SCHEMBL19284721 0.78 MTNR1A (0.54) MTNR1ATP53MAPTIDO1KDM1A
SCHEMBL31043018 0.76 MTNR1A (0.45) MTNR1ATP53RECQLMAPTGAA
SCHEMBL11466368 0.76 MTNR1A (0.49) MTNR1AMAPTIDO1KDM1ASLC6A4
SCHEMBL30477104 0.76 SLC6A4 (0.59) MTNR1ATP53MAPTIDO1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509579-B2 Thermoplastic resin and optical lens including same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-12-30 US disclosed
CN-115996931-B Cyclic diol compound, process for producing the compound, and use of the compound 新日本理化株式会社 2025-04-01 CN disclosed
US-20230399510-A1 THERMOPLASTIC RESIN AND OPTICAL LENS INCLUDING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-12-14 US disclosed
EP-4239010-A1 THERMOPLASTIC RESIN AND OPTICAL LENS INCLUDING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-09-06 EP disclosed
CN-116323753-A Thermoplastic resin and optical lens comprising the same 三菱瓦斯化学株式会社 2023-06-23 CN disclosed
CN-115996931-A Cyclic diol compound, process for producing the compound, and use of the compound 新日本理化株式会社 2023-04-21 CN disclosed
WO-2022091996-A1 THERMOPLASTIC RESIN AND OPTICAL LENS INCLUDING SAME 三菱瓦斯化学株式会社 2022-05-05 WO disclosed
WO-2022091990-A1 CYCLIC DIOL COMPOUND, PRODUCTION METHOD FOR SAID COMPOUND, AND USE OF SAID COMPOUND 新日本理化株式会社 2022-05-05 WO disclosed
US-9593069-B2 Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis NORTHWESTERN UNIVERSITY (US) 2017-03-14 US disclosed
US-9593069-B2 Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis NORTHWESTERN UNIVERSITY (US) 2017-03-14 US disclosed
US-8722939-B2 Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis NORTHWESTERN UNIVERSITY (US) 2014-05-13 US disclosed
US-8722939-B2 Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis NORTHWESTERN UNIVERSITY (US) 2014-05-13 US disclosed
US-20130345420-A9 SELECTIVE INHIBITORS OF EXCITATORY AMINO ACID TRANSPORTER SUBTYPE 1 (EAAT1/GLAST) BUNCH LENNART (DK) 2013-12-26 US disclosed
US-20120264765-A1 Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis CAMBRIA PHARMACEUTICALS, INC. (US) 2012-10-18 US disclosed
US-20120264765-A1 Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis CAMBRIA PHARMACEUTICALS, INC. (US) 2012-10-18 US disclosed
US-20120035361-A1 SELECTIVE INHIBITORS OF EXCITATORY AMINO ACID TRANSPORTER SUBTYPE 1 (EAAT1/GLAST) BUNCH LENNART (DK) 2012-02-09 US disclosed
WO-2011059821-A2 CYCLOHEXANE-1,3-DIONES FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS CAMBRIA PHARMACEUTICALS, INC. (US) 2011-05-19 WO disclosed
WO-2010066253-A1 SELECTIVE INHIBITORS OF EXCITATORY AMINO ACID TRANSPORTER SUBTYPE 1 (EAAT1 /GLAST) BUNCH, LENNART (DK) 2010-06-17 WO disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035361-A1 SELECTIVE INHIBITORS OF EXCITATORY AMINO ACID TRANSPORTER SUBTYPE 1 (EAAT1/GLAST) SLC1A1, SLC1A2, SLC1A3 MTNR1A 696/4885TP53 4828/4885RECQL 4587/4885
US-12509579-B2 Thermoplastic resin and optical lens including same RIF1, POT1, LAS1L MTNR1A 2129/4885TP53 2807/4885RECQL 403/4885
US-20120264765-A1 Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis SMN1; SMN2, HTT, CPT1B MTNR1A 1267/4885TP53 4547/4885RECQL 527/4885
US-20130345420-A9 SELECTIVE INHIBITORS OF EXCITATORY AMINO ACID TRANSPORTER SUBTYPE 1 (EAAT1/GLAST) SLC1A1, SLC1A2, SLC1A3 MTNR1A 696/4885TP53 4828/4885RECQL 4587/4885
US-20070027150-A1 2-Amino-quinazolin-5-ones TK1, TK2, SLC1A5 MTNR1A 776/4885TP53 41/4885RECQL 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.